Analyst Update: Amazon.com, Inc., Devon Energy Corp, and Relypsa Inc

Analysts revised their ratings and price targets on Amazon.com, Inc. (NASDAQ:AMZN), Devon Energy Corp (NYSE:DVN), and Relypsa Inc (NASDAQ:RLYP)

Josh Selway

Jun 7, 2016 at 2:17 PM

Analysts are weighing in on e-tail stock Amazon.com, Inc. (NASDAQ:AMZN), oil-and-gas stock Devon Energy Corp (NYSE:DVN), and drugmaker Relypsa Inc (NASDAQ:RLYP). Here's a quick roundup of today's brokerage notes on AMZN, DVN, and RLYP.

Last month Bernstein set a brow-raising $1,000 price target on AMZN, while MKM Partners last week said Amazon.com could become the largest U.S. company in just a few years. Today it's Oppenheimer singing the e-commerce company's praises, raising its price target to $930 from $780, citing increased profitability in its Amazon Web Services unit. Still, Amazon.com, Inc. is down 0.4% at $723.70. Options volume is also running well below the intraday average, despite rather muted premiums on near-term options, according to AMZN's Schaeffer's Volatility Index (SVI) of 20% -- just 4 percentage points from an annual low. In other news, Amazon Restaurants has launched free one-hour delivery on Prime Now in Atlanta and Miami.

Ahead of the company's shareholders meeting tomorrow, DVN this morning received a price-target increase to $40 from $37 at Raymond James -- right in line with the stock's average 12-month price target of $38.66. Moreover, 82% of covering analysts recommend buying Devon Energy Corp. While the stock is still far removed from its year-over-year breakeven mark of $62.50, the shares have been strong recently, outperforming the S&P 500 Index (SPX) by 45 percentage points during the past three months. Today, DVN is up 3.4% at $38.84 on pace for its best close since Dec. 4.

A downgrade to "underweight" from "equal weight" at Morgan Stanley has RLYP down 3.6% at $19.53 -- though the stock's 200-day moving average is holding up as support. It's been an up-and-down year for the stock, which currently sits 31% below breakeven in 2016. As such, short interest on Relypsa Inc still sits at all-time highs, with close to 15 million shares sold short.

For other stocks in analysts' crosshairs, read Analyst Upgrades: Sodastream International Ltd, Sarepta Therapeutics Inc, and United Natural Foods, Inc. and Analyst Downgrades: Alexion Pharmaceuticals, Inc., WPX Energy Inc, and Godaddy Inc.

Follow @Schaeffers

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released!